July 24 (Reuters) - Kodiak Sciences KOD.O will abandon further development of its lead drug to treat a type of eye disease after it failed in two late-stage studies, the company said on Monday, ...

Please provide your email address to receive an email when new articles are posted on . Gentex Corp. has announced its acquisition of eSight to develop and manufacture mobile electronic eye wear for ...

June 10 (Reuters) - Skye Bioscience (SKYE.O), opens new tab said on Monday it will discontinue development of its experimental eye disease treatment after the drug failed to meet the main goal of a ...

CHICAGO --- Aerobic glycolysis, the process by which cells transform glucose into lactate, is key for eye development in mammals, according to a new Northwestern Medicine study published in Nature ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Drug development for neurodegenerative diseases is struggling with one of its most intractable barriers: the slow, variable, and subjective nature of clinical endpoints Traditional assessment scales, ...

A new study from UCLA Health shows that a cardiovascular risk score already used routinely in primary care can predict who will develop serious eye diseases years later. Researchers found that people ...

Adds shares in paragraph 1, details of trial in paragraphs 2-3 July 24 (Reuters) - Kodiak Sciences Inc KOD.O decided to discontinue development of its experimental drug to treat a type of eye disorder ...